539428 Stock Overview
Tejnaksh Healthcare Limited, together with its subsidiary provides hospital and healthcare services in India.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Tejnaksh Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹24.35 |
| 52 Week High | ₹40.00 |
| 52 Week Low | ₹22.91 |
| Beta | 0.77 |
| 1 Month Change | -6.17% |
| 3 Month Change | -21.83% |
| 1 Year Change | -33.69% |
| 3 Year Change | -26.21% |
| 5 Year Change | -1.32% |
| Change since IPO | 489.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539428 | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -3.4% | -1.8% | -2.1% |
| 1Y | -33.7% | 65.0% | 45.3% |
Return vs Industry: 539428 underperformed the Indian Healthcare industry which returned 65% over the past year.
Return vs Market: 539428 underperformed the Indian Market which returned 45.3% over the past year.
Price Volatility
| 539428 volatility | |
|---|---|
| 539428 Average Weekly Movement | 6.0% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 539428's share price has been volatile over the past 3 months.
Volatility Over Time: 539428's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 38 | Ashish Rawandale-Patil | www.tejnaksh.com |
Tejnaksh Healthcare Limited, together with its subsidiary provides hospital and healthcare services in India. The company offers health care services through urology clinics, urology hospitals, and dental super specialty clinics. It also operates multi-specialty hospitals, super-specialty hospitals, education institutes, pathology labs, super specialty training institutes, simulation institutes, and stone analysis labs.
Tejnaksh Healthcare Limited Fundamentals Summary
| 539428 fundamental statistics | |
|---|---|
| Market cap | ₹507.03m |
| Earnings (TTM) | ₹12.53m |
| Revenue (TTM) | ₹120.47m |
39.5x
P/E Ratio4.1x
P/S RatioIs 539428 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539428 income statement (TTM) | |
|---|---|
| Revenue | ₹120.47m |
| Cost of Revenue | ₹32.68m |
| Gross Profit | ₹87.79m |
| Other Expenses | ₹75.27m |
| Earnings | ₹12.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 72.87% |
| Net Profit Margin | 10.40% |
| Debt/Equity Ratio | 24.3% |
How did 539428 perform over the long term?
See historical performance and comparison